<p><strong>Background: </strong>Due to the high transmission ability of the SARS-CoV-2 virus, front-line healthcare workers (HCWs) are at a greater risk of contracting the infection during the management of COVID patients. As a result, prevention measures against COVID-19 disease transmission like personal protective equipment (PPE) and frequent hand washing have become a necessity. While these measures are effective against COVID-19 transmission, they have negative implications as well, one of which is their detrimental effects on the skin. The objective of the study was to understand the prevalence and pattern of cutaneous manifestations among HCWs caring for COVID patients.</p><p><strong>Methods: </strong>A descriptive study on HCWs caring for COVID-19 patients was conducted at a designated COVID hospital from September to October 2020. Data on protective measures taken and cutaneous examination findings were recorded and analyzed.</p><p><strong>Results: </strong>Among 310 HCWs in this study, 137 HCWs (44.19%) had skin rash. The highest incidence of cutaneous manifestations was seen among nurses (48.33%), followed by doctors (42.29%) and support staff (33.33%). Hand eczema (43.80%) was the most common manifestation, followed by acne (22.63%), hair fall (18.98%), sweat dermatitis (11.68%), pressure dermatitis (10.22%), irritant contact dermatitis (7.30%). Seborrhea capitis, pruritus, xerosis, hyperpigmentation, urticaria, tinea corporis, and eczema over legs were the other cutaneous manifestations seen in this study.</p><p><strong>Conclusions: </strong>Nearly half of the HCWs in this study had cutaneous manifestations. Hence, there is a need to educate the HCWs regarding best practices for the prevention of skin damage caused by PPE and frequent hand wash.</p>

<p class="abstract"><strong>Background: </strong>Vitiligo is characterized by milky-white macules affecting the skin and mucous membranes. It occurs due to the progressive loss of functioning melanocytes from the affected areas. It may affect any age group and gender. Genetic, immunological, neural, and self-destructive mechanisms may be involved in its pathogenesis. Both autoimmune and non-autoimmune disorders have been reported to be associated with vitiligo.</p><p class="abstract"><strong>Methods: </strong>This is a descriptive study conducted in the Department of DVL of a teaching hospital from August 2020 to November 2021. 50 vitiligo patients were enrolled in the study. Relevant data was recorded using the customized case proforma and analyzed.</p><p class="abstract"><strong>Results: </strong>Majority of the patients belonged to the age group of 21-30 years (28%). Males (54%) outnumbered females. The mean duration of the disease was 51.6 months. The familial incidence of vitiligo was 18%. Majority of the cases were of vitiligo vulgaris type (50%). Koebnerization was seen in 20% and leukotrichia in 34% of the cases. 14% of cases had other coexisting cutaneous diseases. Urticaria (4%) was the most common followed by alopecia areata, acne, atopic dermatitis and psoriasis. 44% of the study population had systemic comorbidities. Iron deficiency anemia was the most common seen in 20% of cases followed by hypothyroidism, diabetes mellitus, dyslipidemia and hypertension.</p><p class="abstract"><strong>Conclusions: </strong>A detailed history, comprehensive cutaneous and systemic examination, relevant laboratory workup is mandatory in a newly diagnosed patient with vitiligo. A regular follow-up and psychiatric evaluation is also necessary to reduce the disease burden.</p>